A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation
- Sponsor
- Johnson & Johnson Medical (Shanghai) Ltd.
- Study ID
- NCT07511166
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
The main purpose of the study is to assess how well the standard ablation procedure (Varipulse Catheter) works over long term when used with different types of anesthesia in participants with symptomatic paroxysmal atrial fibrillation (PAF, irregular heartbeat that comes and goes on its own, causing noticeable symptoms like a racing heart, or shortness of breath).
Key Dates
- First listed
- Apr 6, 2026
- Start date
- Jul 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Feb 9, 2028
- Completion
- Mar 28, 2028
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: General Anesthesia GroupParticipants undergoing ablation for treatment of symptomatic Paroxysmal Atrial Fibrillation (PAF) under general anesthesia will undergo pulsed field ablation (PFA) with Varipulse PFA catheter system including Varipulse catheter and Trupulse generator.
- Arm: Non-General Anesthesia GroupParticipants undergoing ablation for treatment of symptomatic PAF under the non-general anesthesia, including participants with deep sedation and conscious sedation will undergo PFA with the Varipulse PFA catheter system including Varipulse catheter and Trupulse generator.
Primary Outcome Measure
Freedom From Documented (Symptomatic and Asymptomatic) Atrial Tachyarrhythmias Episode [ Time Frame: Day 91 to Day 365 post index procedure ]
Central Contacts
- YanTing Zhang13162835013
Find similar trials
Related Studies
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Dallas, Texas
- Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac SurgeryPHASE2 · Not Yet Recruiting · Baystate Medical Center · Melrose, Massachusetts
- Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial FibrillationPHASE4 · Recruiting · University of Illinois at Chicago · Chicago, Illinois
- Left Atrial Appendage Occlusion Registry (LAAO Registry)Recruiting · American College of Cardiology · Washington D.C., District of Columbia